Dengue in childhood;La dengue chez l'enfant

Medecine Therapeutique Pediatrie

Volumn 15, Issue 2, 2012, Pages 57-78

  Hatchuel, Yves ^a  

^a CENTRE HOSPITALIER UNIVERSITAIRE DE FORT DE FRANCE   (France)

Author keywords

Dengue; Hemophagocytic syndrome; Innate immunity; Sickle cell disease

Indexed keywords

EID: 84862903107     PISSN: 12865494     EISSN: 19524188     Source Type: Journal    
DOI: 10.1684/mtp.2012.0432     Document Type: Article

References (54)

1. WHO. Dengue: guidelines for diagnosis, treatment, prevention and control. New edition. A joint publication of the World Health Organization (WHO) and the Special Programme for Research and Training in Tropical Diseases (TDR). WHO Library Cataloguingin-Publication Data (téléchargeable sur http://www.who.int/csr/resources/publications/dengue-9789241547871/en/).
2. Halstead SB. Seminar dengue. Lancet 2007;370:1644-52.
3. Césaire R, Cabié A, Djossou F, et al. Aspects récents de la dengue dans les départements français d'Amérique. Virologie 2008;12:1-7.
4. La Ruche G, Souares Y, Armengaud A, et al. First two autochthonous dengue virus infections in metropolitan France, September 2010. Euro Surveill 2010;15(pii: 19676; http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId= 19676).
5. Basu A, Chaturvedi UC. Vascular endothelium: the battlefield of dengue viruses. Immunol Med Microbiol 2008;53:287-99.
6. Surasombatpattana P, Hamel R, Patramool S, et al. Dengue virus replication in infected human keratinocytes leads to activation of antiviral innate immune responses. Infect Genet Evol 2011;11:1664-73.
7. Navarro-Sanchez E, Altmeyer R, Amara A, et al. Dendritic-cellspecific ICAM3-grabbing non-integrin is essential for the productive infection of human dendritic cells by mosquito-cell-derived dengue viruses. EMBO Rep 2003;4.
8. Noisakran S, Chokephaibulkit K, Songprakhon P, et al. A reevaluation of the mechanisms leading to dengue hemorrhagic fever. Ann N Y Acad Sci 2009;1171(suppl. 1).
9. Endy P, Nisalak A, Chunsuttitwat S, et al. Relationship of preexisting dengue virus (DV) neutralizing antibody levels to viremia and severity of disease in a prospective cohort study of DV infection in Thailand. Timothy JID 2004;189(15 March).
10. Dejnirattisai W, Jumnainsong A, Onsirisakul N, et al. Crossreacting antibodies enhance dengue virus infection in humans. Science 2010;328:745-8.
11. Deparis X, Maréchal V, Matheus S. Mécanismes physiopathologiques de la dengue: revue critique des hypothèses. Med Trop 2009;69:351-7.
12. Thomas L, Verlaeten O, Cabié A, Kaidomar S, Moravie V, Martial J. Influence of the dengue serotype, previous dengue infection, and plasma viral load on clinical presentation and outcome during a dengue-2 and dengue-4 co-epidemic. Am J Trop Med Hyg 2008;78:990-8. (Pubitemid 351967821)
13. Tolfvenstam T, Lindblom A, Schreiber MJ, et al. Characterization of early host responses in adults with dengue disease. BMC Infect Dis 2011;11:209.
14. Lee YR, Liu MT, Lei HY, et al. MCP-1, a highly expressed chemokine in dengue haemorrhagic fever/dengue shock syndrome patients may cause permeability change, possibly through reduced tight junctions of vascular endothelium cells. J Gen Virol 2006;87:3623-30. (Pubitemid 44816994)
15. Azeredo EL, De Oliveira-Pinto LM, Zagne SM, Cerqueira DI, Nogueira RM, Kubelka CF. NK cells, displaying early activation, cytotoxicity and adhesion molecules, are associated with mild dengue disease. Clin Exp Immunol 2006;143:345-56.
16. Kurane I, Innis BL, Nimmannitya S, et al. Activation of T lymphocytes in dengue virus infections. J Clin Invest 1991;88:1473-80.
17. Veerakul G, Sanpakit K, Tanphaichitr VS, Mahasandana C, Jirarattanasopa N. Secondary hemophagocytic lymphohistiocytosis in children: an analysis of etiology and outcome. Med Assoc Thai 2002;85(suppl. 2):S530-41. (Pubitemid 35345819)
18. Ramachandran B, Balasubramanian S, Abhishek N, Ravikumar KG, Ramanan AV. Profile of hemophagocytic lymphohistiocytosis in children in a tertiary care hospital in India. Indian Pediatr 2011;48:31-5.
19. Phuong CX, Nhan NT, Kneen R, et al. Clinical diagnosis and assessment of severity of confirmed dengue infections in Vietnamese children: isthe World Health Organization classification system helpful? Am J Trop Med Hyg 2004;70:172-9. (Pubitemid 38200522)
20. Thomas L, Brouste Y, Najioullah F, et al. Predictors of severe manifestations in a cohort of adult dengue patients. J Clin Virol 2010;48:96-9.
21. World Health Organization, Regional Office for Southeast Asia. Comprehensive guidelines for prevention and control of dengue and dengue haemorrhagic fever. 2nd edition 2011 (http://www.searo.who.int/linkfiles/dengue- dhf-prevention&control-guidelines-rev.pdf).
22. Hospice C. La dengue chez l'enfant: étude rétrospective clinique et biologique des enfants hospitalisés durant l'épidémie 2007-2008 en Martinique. Thèse UAG, no 2009AGUY0287 (soutenue le 9 novembre 2009).
23. Chaiyaratana W, Chuansumrit A, Atamasirikul K, Tangnararatchakit K. Serum ferritin levels in children with dengue infection. Southeast Asian J Trop Med Public Health 2008;39:832-6.
24. Carlos CC, Oishi K, Cinco MTDD, et al. Comparison of clinical features and hematologic abnormalities between dengue fever and dengue hemorrhagic fever among children in the Philippines. Am J Trop Med Hyg 2005;73:435-40. (Pubitemid 41278725)
25. Chuansumrit A, Phimolthares V, Tardtong P, et al. Transfusion requirements in patients with dengue hemorrhagic fever. Southeast Asian J Trop Med Public Health 2000;31:10-4.
26. Kumarasena RS, Mananjala Senanayake S, Sivaraman K, et al. Intravenous N-acetylcysteine in dengue-associated acute liver failure. Hepatol Int 2010;4:533-4.
27. Thong MK. Dengue shock syndrome and acute respiratory distress syndrome. Comment on Lancet 1998;352:971-7.
28. Wang CC, Wu CC, Liu JW, et al. Chest radiographic presentation in patients with dengue hemorrhagic fever. Am J Trop Med Hyg 2007;77:291-6.
29. Varatharaj A. Encephalitis in the clinical spectrum of dengue infection. Neurol India [serial online] 2010;58:585-91 (consultable sur: http://www.neurologyindia.com/text.asp?2010/58/4/585/68655; cited 2012 Feb. 26)
30. Khongphatthanayothin A, Lertsapcharoen P, Supachokchaiwattana P, et al. Myocardial depression in dengue hemorrhagic fever: prevalence and clinical description. Pediatr Crit Care Med 2007;8:524-9. (Pubitemid 350076457)
31. Béral L, Merle H, David D. Ocular complications of dengue fever. Ophthalmology 2008;115:1100-1.
32. Su DHW, Bacsal K, Chee SP, et al. Prevalence of dengue maculopathy in patients hospitalized for dengue fever. Ophthalmology 2007;114:1743-7.
33. López-Gómez M. Úlceras aftosas genitales en un caso de dengue importado. Rev Clin Esp 2004;204:440-3.
34. Bravo JR, Guzman MG, Kouri GP. Why dengue haemorrhagic fever in Cuba? Individual risk factors for dengue haemorrhagic fever/dengue shock syndrome (DHF/DSS). Trans R Soc Trop Med Hyg 1987;81:816-20.
35. Pouliot SH, Xiong X, Harville E, et al. Maternal dengue and pregnancy outcome: a systematic review. Obstet Gynecol Surv 2010;65:107-18.
36. Mekmullica J, Pancharoen C, Deerojanawong J, Lertsapcharoen P, Thisyakorn U, Thisyakorn C. Concomitant dengue infection and Kawasaki disease in an infant: a case report and literature review. J Med Assoc Thai 2005;88:436-9. (Pubitemid 40791258)
37. Najioullah F, Combet E, Paturel L, et al. Prospective evaluation of nonstructural 1 enzyme-linked immunosorbent assay and rapid immunochromatographic tests to detect dengue virus in patients with acute febrile illness. Diagn Microbiol Infect Dis 2011;69:172-8.
38. Nhan NT, Thanh Phuong CX, Kneen R, Wills B, My NV, Que Phuong NT. Acute management of dengue shock syndrome: a randomized double-blind comparison of4 intravenous fluid regimens in the first hour. Clin Infect Dis 2001;32:204-13. (Pubitemid 32524789)
39. Hung NT, Lan NT, Lei HY, Lin YS, Lien LB, Huang KJ. Volume replacement in infants with dengue hemorrhagic fever/dengue shock syndrome. Am J Trop Med Hyg 2006;74:684-91.
40. Thomas L, Kaidomar S, Kerob-Bauchet B, et al. Prospective observational study of low thresholds for platelet transfusion in adult dengue patients. Transfusion 2009;49:1400-11 (epub 2009 March 20).
41. Chuansumrita A, Tangnararatchakita K, Lektakulb Y, et al. The use of recombinant activated factor VII for controlling life-threatening bleeding in dengue shock syndrome. Blood Coagul Fibrinolysis 2004;15.
42. Cam BV, Cam BV, Tuan DT, et al. Randomized comparison of oxygen mask treatment vs. nasal continuous positive airway pressure in dengue shock syndrome with acute respiratory failure. J Trop Pediatr 2002;48:335-9. (Pubitemid 36024533)
43. Protection personnelle antivectorielle ou Protection contre les insectes piqueurs et les tiques. Recommandations de bonnes pratiques. Téléchargeable sur: www.medecine-voyages.fr/download.php5?id=223.
44. Marcombe S. Résistance d'Aedes aegypti aux insecticides à la Martinique et implications dans la lutte contre la dengue. Thèse université de Montpellier II. Résumé dans Bulletin de veille sanitaire Antilles-Guyanes; no 7. Septembre 2011.
45. Wilder-Smith A, Lover A, Kittayapong P, Burnham G. Hypothesis: impregnated school uniforms reduce the incidence of dengue infections in school children. Med Hypotheses 2011;76:861-2.
46. Walker T, Johnson PH, Moreira LA, et al. The wMel Wolbachia strain blocks dengue and invades caged Aedes aegypti populations. Nature 2011;476:450-3.
47. Tan GK, Alonso S. Pathogenesis and prevention of dengue virus infection: state-of-the-art. Curr Opin Infect Dis 2009;22:302-8.
48. Guy B, Saville M, Lang J. Development of Sanofi Pasteur tetravalent dengue vaccine. Hum Vaccin 2010;6:696-705.
49. Rajapakse S. Corticosteroids in the treatment of dengue illness. Trans R Soc Trop Med Hyg 2009;103:122-6 (epub 2008 September 11).
50. http://www.afssaps.fr/var/afssaps-site/storage/original/application/ fe5601ed8b7074612dce201304fb739b.pdf.
51. Dimaano EM, Saito M, Honda S, et al. Lack of efficacy of high-dose intravenous immunoglobulin treatment of severe thrombocytopenia in patients with secondary dengue virus infection. Am J Trop Med Hyg 2007;77:1135-8. (Pubitemid 351837807)
52. Srichaikul T, Punyagupta S, Kanchanapoom T, Chanokovat C, Likittanasombat K, Leelasiri A. Hemophagocytic syndrome in dengue hemorrhagic fever with severe multiorgan complications. J Med Assoc Thai 2008;91:104-9. (Pubitemid 351263352)
53. Sariol CA, Martinez M, Rivera F, et al. Decreased dengue replication and an increased antiviral humoral response with the use of combined Toll-like receptor 3 and 7/8 agonists in macaques. PLoS One 2011;6.
54. Shresta S, Sharar KL, Prigozhin DM, Beatty PR, Harris E. Murine model for dengue virus-induced lethal disease with increased vascular permeability. J Virol 2006;80:10208-17. (Pubitemid 44522614)